Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-12-03

Clinical Trial Update: Dorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dorzolamide-timolol drops administered with injections for wet AMD, age-related macular degeneration, diabetic macular edema, and retin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • dorzolamide-timolol drops with injections (dorzolamide-timolol)

Snippet

Sponsor: Wills Eye | Conditions: Wet Macular Degeneration, Age-related Macular Degeneration | Phase 2 | Status: COMPLETED | Results posted: 2019-12-03